What’s curious about the new leadership arrangement is that CEO Stephen King, who resigned from the BoD as part of the settlement, no longer has a job to do insofar as another executive is in charge of the company’s sole operating business: the contract manufacturer, Avid Biosciences.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.